EIF2A and prion disease: In line with a central role of phospho-eIF2α in prion disease, treatment of prion-infected mice with a specific PERK kinase inhibitor restored global protein synthesis and abrogated development of clinical prion disease in mice, with neuroprotection observed throughout the brain42.